×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| ALBERT DAVID LTD. | 740.76 | -93.88 | 830.83 | -16.45 | 509.0 | 12.6 |
| ZIM Laboratories Limited | 980.85 | 40.01 | 963.3 | 0.82 | 463 | 30.1 |
| JENBURKT PHARMACEUTICALS LTD. | 384.75 | 65.08 | 368.93 | 14.75 | 443 | 14.1 |
Albert David Ltd.,, with Security Code 524075, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 92.3 | 74.5 | 81.4 | 91.9 | 93.1 | 88.2 | 89.0 | 89.3 | 98.4 | 83.0 |
| Expenses | 78.1 | 66.3 | 71.8 | 79.0 | 77.2 | 79.9 | 79.5 | 88.5 | 92.2 | 82.4 |
| Operating Profit | 14.2 | 8.3 | 9.6 | 13.0 | 16.0 | 8.4 | 9.6 | 0.9 | 6.2 | 0.7 |
| OPM % | 15.42% | 11.11% | 11.78% | 14.13% | 17.14% | 9.46% | 10.75% | 0.98% | 6.32% | 0.81% |
| Other Income | 13.5 | 7.5 | 0.0 | 18.1 | 12.1 | 16.9 | 10.4 | 23.1 | 20.6 | -9.0 |
| Interest | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Depreciation | 2.1 | 2.1 | 2.3 | 1.9 | 1.5 | 1.7 | 1.8 | 1.8 | 1.7 | 1.7 |
| Profit before tax | 25.6 | 13.6 | 7.2 | 29.2 | 26.5 | 23.4 | 18.1 | 22.1 | 25.1 | -10.2 |
| Tax % | 21.3% | 22.3% | 48.1% | 19.5% | 23.5% | 20.1% | 28.7% | 14.6% | 28.1% | -7.6% |
| Net Profit | 20.1 | 10.5 | 3.7 | 23.5 | 20.3 | 18.7 | 12.9 | 18.8 | 18.1 | -9.4 |
| EPS in Rs | 35.29 | 18.48 | 6.54 | 41.16 | 35.57 | 32.8 | 22.63 | 33.02 | 31.67 | -16.45 |
| Metrics |
|---|
| Sales |
| Expenses |
| Operating Profit |
| OPM % |
| Other Income |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| Net Profit |
| EPS in Rs |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 3% |
| 3 Years: | 14% |
| TTM: | 1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 23% |
| 3 Years: | 52% |
| TTM: | -39% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 15% |
| 3 Years: | 18% |
| 1 Year: | -34% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|